For example, within TMEs of breast and prostate cancers, it was observed that the expression levels of angiogenic factors such as vascular endothelial growth factor (VEGF) and Interleukin 6 (IL-6) are upregulated by the MSCs. This evidence concerns the gene IL6 and Familial prostate cancer.